Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021.
Corporate Participants:
Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions
Robert B. Ford — President and Chief Executive Officer
Robert E. Funck — Executive Vice President, Finance and Chief Financial Officer
Analysts:
Bob Hopkins — Bank of America Merrill Lynch — Analyst
Matthew Taylor — UBS — Analyst
Robert Marcus — J.P. Morgan — Analyst
David Lewis — Morgan Stanley — Analyst
Lawrence Biegelsen — Wells Fargo — Analyst
Joanne Wuensch — Citi — Analyst
Vijay Kumar — Evercore ISI — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results
Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where
What to look for when United Airlines (UAL) reports its Q4 2025 earnings results
Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
Listen On
